MedPath

Mechanisms of the Nicotine Metabolism Effect on Tobacco Dependence

Not Applicable
Completed
Conditions
Cigarette Smoking
Interventions
Behavioral: Smoking abstinence
Registration Number
NCT01627392
Lead Sponsor
University of California, San Francisco
Brief Summary

The purpose of the study is to learn more about tobacco dependence and nicotine metabolism in African-Americans and whites, by studying to see if how fast a person metabolizes nicotine (how the body breaks down nicotine into inactive compounds) affects how dependent they are on smoking cigarettes. The investigators believe that people with a faster rate of metabolism may have more severe nicotine withdrawal symptoms and also may have a harder time trying to quit smoking.

Detailed Description

Our studies will use the nicotine metabolite ratio (NMR) (the ratio between the nicotine metabolites 3'hydroxycotinine and cotinine)as a simple and clinically feasible biomarker for the rate of nicotine metabolism. The investigators hypothesize that a faster rate of metabolism leads to faster elimination of nicotine from the body and a more rapid dissipation of brain tolerance to nicotine in the interval between cigarettes, leading in turn to (1) more severe nicotine withdrawal symptoms and (2) greater subjective reward from the cigarette smoked following deprivation. These effects would help to explain why smokers with faster rates of nicotine metabolism have a poorer response to smoking cessation therapy when compared to those with slower rates of metabolism.

The investigators will explore the relationship of the NMR to the endophenotypes of withdrawal, craving and reward, with the assumption that these factors are likely intermediaries for the mechanism linking nicotine metabolism to tobacco dependence and smoking cessation rates with pharmacotherapy. Our study design uses a brief (6 hour) interval of smoking abstinence followed by a "reward" cigarette to elicit the subjective responses relating to withdrawal and reward. Because smoking behavior and severity of nicotine dependence vary by race and sex the investigators will also compare the relationship between NMR and withdrawal and reward in African American vs white smokers and in men vs women.

Secondary analyses will examine whether nicotine half-life mediates the observed effects of NMR on primary response measures.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
305
Inclusion Criteria
  • African-American or Caucasian
  • Age 18-70 years
  • Regular smoker of 5 or more cigarettes per day
  • Saliva cotinine of 100 ng/ml or greater
Read More
Exclusion Criteria
  • Obese (BMI > 38) or underweight (BMI < 17)
  • Major systemic or psychiatric condition
  • Medications that are inducers of CYP2A6
  • History of alcohol abuse
  • Positive drug urine tox test
  • Pregnancy or breast feeding
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Smoking abstinenceSmoking abstinence-
Primary Outcome Measures
NameTimeMethod
Nicotine withdrawal symptoms6 hours post nicotine load

Total withdrawal score as measured by Minnesota Nicotine Withdrawal Scale

Secondary Outcome Measures
NameTimeMethod
Cognitive performance6 hours post nicotine load

Cognitive performance will be measured by n-back computerized testing

Smoking behavior: number of cigarettes90 minutes post-abstinence

Smoking behavior will be measured by number of cigarettes during a monitoring period following the 3rd (reward) cigarette of the protocol

Smoking behavior: number of puffs per cigarette90 minutes post-abstinence

Smoking behavior will be measured by number of puffs per cigarette during a monitoring period following the 3rd (reward) cigarette of the protocol

Smoking behavior: time to first post-reward cigarette90 minutes post-abstinence

Smoking behavior will be measured by time to first post-reward cigarette during a monitoring period following the 3rd (reward) cigarette of the protocol

Trial Locations

Locations (1)

San Francisco General Hospital

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath